Growth inhibition and induction of phenotypic alterations in MCF-7 breast cancer cells by an IMP dehydrogenase inhibitor.
D000255:Adenosine Triphosphate / Q000378:metabolism; D001943:Breast Neoplasms / Q000201:enzymology / Q000473:pathology*; D002470:Cell Survival / Q000187:drug effects; D004305:Dose-Response Relationship, Drug; D005260:Female; D006151:Guanosine / Q000494:pharmacology; D006160:Guanosine Triphosphate / Q000378:metabolism; D006801:Humans; D007168:IMP Dehydrogenase / Q000037:antagonists & inhibitors*; D007658:Ketone Oxidoreductases / Q000037:antagonists & inhibitors*; D008938:Mitosis / Q000187:drug effects; D009173:Mycophenolic Acid / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D010641:Phenotype; D014407:Tumor Cells, Cultured / Q000187:drug effects
D006151:Guanosine; D006160:Guanosine Triphosphate; D000255:Adenosine Triphosphate; D007168:IMP Dehydrogenase; D007658:Ketone Oxidoreductases; D009173:Mycophenolic Acid